30 Day Trial

BARE BONES content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Reimbursement / Regulatory

Cerapedics was informed by FDA that an advisory committee panel meeting is not required for final review of the Premarket Approval application for i-FACTORPeptide Enhanced Bone Graft. Cerapedics filed a comprehensive response to remaining items from the PMA review of i-FACTOR, including those from a recently completed pre-approval facility inspection. (Cerapedics, Inc., 6/16/15)